The adenosine pathway in immuno-oncology

B Allard, D Allard, L Buisseret, J Stagg - Nature Reviews Clinical …, 2020 - nature.com
Cancer immunotherapy based on immune-checkpoint inhibition or adoptive cell therapy has
revolutionized cancer care. Nevertheless, a large proportion of patients do not benefit from …

Adenosine and inflammation: here, there and everywhere

S Pasquini, C Contri, PA Borea, F Vincenzi… - International journal of …, 2021 - mdpi.com
Adenosine is a ubiquitous endogenous modulator with the main function of maintaining
cellular and tissue homeostasis in pathological and stress conditions. It exerts its effect …

Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases

BN Cronstein, M Sitkovsky - Nature Reviews Rheumatology, 2017 - nature.com
Adenosine, a nucleoside derived primarily from the extracellular hydrolysis of adenine
nucleotides, is a potent regulator of inflammation. Adenosine mediates its effects on …

Focusing on adenosine receptors as a potential targeted therapy in human diseases

WI Effendi, T Nagano, K Kobayashi, Y Nishimura - Cells, 2020 - mdpi.com
Adenosine is involved in a range of physiological and pathological effects through
membrane-bound receptors linked to G proteins. There are four subtypes of adenosine …

Adenosine signaling and the immune system: When a lot could be too much

L Antonioli, M Fornai, C Blandizzi, P Pacher, G Haskó - Immunology letters, 2019 - Elsevier
Adenosine is increasingly recognized as a key mediator of the immune response. Signals
delivered by extracellular adenosine are detected and transduced by G-protein-coupled cell …

The A3 adenosine receptor: history and perspectives

PA Borea, K Varani, F Vincenzi, PG Baraldi… - Pharmacological …, 2015 - ASPET
By general consensus, the omnipresent purine nucleoside adenosine is considered a major
regulator of local tissue function, especially when energy supply fails to meet cellular energy …

The purinergic system as a pharmacological target for the treatment of immune-mediated inflammatory diseases

L Antonioli, C Blandizzi, P Pacher, G Haskó - Pharmacological reviews, 2019 - ASPET
Immune-mediated inflammatory diseases (IMIDs) encompass a wide range of seemingly
unrelated conditions, such as multiple sclerosis, rheumatoid arthritis, psoriasis, inflammatory …

Immunomodulatory and neuroprotective effects of inosine

G Haskó, MV Sitkovsky, C Szabo - Trends in pharmacological sciences, 2004 - cell.com
Adenosine has been considered as a potential immunomodulatory and neuroprotective
agent for 30 years. Inosine, a major degradation product of adenosine, was thought …

Pharmacological and therapeutic effects of A3 adenosine receptor agonists

P Fishman, S Bar-Yehuda, BT Liang, KA Jacobson - Drug discovery today, 2012 - Elsevier
The A3 adenosine receptor (A3AR) coupled to Gi (inhibitory regulative guanine nucleotide-
binding protein) mediates anti-inflammatory, anticancer and anti-ischemic protective effects …

The A3 adenosine receptor: an enigmatic player in cell biology

S Gessi, S Merighi, K Varani, E Leung… - Pharmacology & …, 2008 - Elsevier
Adenosine is a primordial signaling molecule present in every cell of the human body that
mediates its physiological functions by interacting with 4 subtypes of G-protein-coupled …